Sentences with phrase «tuberculosis vaccine»
A tuberculosis vaccine is a medicine that helps protect people from getting tuberculosis, a bacterial infection that mainly affects the lungs. The vaccine helps the body build defenses to fight off the germs that cause tuberculosis, keeping people healthy. Full definition
Product Development Team in Tuberculosis Vaccine Initiative BCG working group in World Health Organisation
nibsc.org
We are also interested in the study of the roles of caspase - 2 in host responses induced by other vaccines (e.g., tuberculosis vaccine BCG).
Darrick previously worked at Corixa Corporation, where he led a new tuberculosis vaccine into human clinical trials and assisted as group leader for analytical biochemistry working on adjuvants and a commercial, radiolabeled mAb for non-Hodgkins lymphoma.
Progress in tuberculosis vaccine development and host - directed therapies — a state of the art review Kaufmann, S.H.E., Lange C., Rao M., Balaji K.N., Lotze M., Schito M., Zumla A.I., Maeurer M. Lancet Respir Med., 2014 2 (4): 301 - 20.
If combined with other changes to the current tuberculosis vaccine, called BCG, the drying technique could help save hundreds of thousands of lives, says Jerry Sadoff, president and CEO of the Aeras Global TB Vaccine Foundation and co-author of a report describing the advance.
When results from a landmark tuberculosis vaccine trial in Cape Town, South Africa were published in The Lancet in February 2013, the headlines were grim, despite hopes that the trial would point toward a successful way to thwart one of the globe's biggest public health threats.
«Tuberculosis vaccine passes important milestone.»
Similar to these projects, IDRI's subunit tuberculosis vaccine, ID93, also utilizes adjuvants that induce a cell - mediated immune response, which is required for protection against M. tuberculosis infection in low dose aerosol models of TB.
He led the team that, together with GSK, developed the first defined tuberculosis vaccine to advance to clinical trials, and has developed the first defined vaccines for leishmaniasis, as well as the K39 - based diagnostic tests currently licensed for leishmaniasis.
He currently serves as principal investigator on a $ 11.9 M contract from the National Institutes of Health (NIH) to develop a thermostable tuberculosis vaccine suitable for distribution in developing countries, involving formulation development, cGMP manufacturing, and clinical testing.
Stoever previously served as Vice President of External Affairs at Aeras, a nonprofit focused on developing next generation tuberculosis vaccines; as President and Founder of Meliora Global LLC, a firm focused on growth strategies for nonprofits and social ventures; and as Managing Director of the Global Network for Neglected Tropical Diseases for the Sabin Institute.
TuBerculosis Vaccine Initiative (TBVI) is a non-profit foundation that facilitates the discovery and development of new, safe and effective TB vaccines that are accessible and affordable for all people.
The DarDar Trial remains the only trial in which a new tuberculosis vaccine has shown efficacy in humans.
An earlier form of the vaccine was used in the DarDar Trial, a seven - year study in Tanzania sponsored by the U.S. National Institutes of Health involving patients with HIV infection who at birth had received BCG, the current tuberculosis vaccine.
The tuberculosis vaccine only works for children.
Studies in several countries have demonstrated that the tuberculosis vaccine BCG, when given early in life, confers some protection against acute leukaemia (Journal of the Royal Society of Medicine, vol 96, p 389).
Children who attend daycare in their first few months are much less likely to develop leukaemia than those who stay at home, for instance, while some tuberculosis vaccines reduce the risk of skin cancer.
He currently serves on over 15 boards and advisory committees, including the Board of Trustees for the Tuberculosis Vaccine Initiative (TBVI), and as Chairman Emeritus of the International Vaccine Institute (IVI).
In addition, he is also a member of the Governing Board of the Tuberculosis Vaccine Initiative (TBVI) and past - chairman of the Human Vaccine Committee of the International Association for Biologicals (IABS) and of the WHO GACVS (Global Advisory Committee on Vaccine Safety).
The BMJ has published an investigation into how researchers interpreted results of animal studies — before moving to human clinical trials — to test a new tuberculosis vaccine.
Tuberculosis vaccines: time to think about the next generation Kaufmann S.H.E. Seminars in Immunology, 2013 25: 172 - 181.
The TuBerculosis Vaccine Initiative (TBVI) is a non-profit foundation that facilitates the discovery and development of new, safe and effective TB vaccines that are accessible and affordable for all people.
He has also participated in technology transfer projects in Brazil and India, where a vaccine formulation center has been constructed to manufacture IDRI - developed adjuvant formulations for clinical trials to evaluate malaria, leishmania, and tuberculosis vaccines.
Before joining IDRI, Tracey worked as a Protocol Development Manager with the HIV Vaccine Trials Network at the Fred Hutchinson Cancer Research Center where she led multi-disciplinary teams in the design and implementation of clinical trials evaluating candidate HIV and tuberculosis vaccines.